Immix Biopharma (IMMX) Operating Expenses (2021 - 2026)
Quarterly results put Operating Expenses at $10.8 million for Q1 2026, up 130.71% from a year ago — trailing twelve months through Mar 2026 was $36.1 million (up 65.74% YoY), and the annual figure for FY2025 was $30.0 million, up 32.11%.
Immix Biopharma has reported Operating Expenses over the past 6 years, most recently at $10.8 million for Q1 2026.
- Operating Expenses reached $10.8 million in Q1 2026 per IMMX's latest filing, down from $10.9 million in the prior quarter.
- Across five years, Operating Expenses topped out at $10.9 million in Q4 2025 and bottomed at $1.3 million in Q1 2022.
- Median Operating Expenses over the past 5 years was $4.7 million (2024), compared with a mean of $5.2 million.
- The largest annual shift saw Operating Expenses skyrocketed 718.38% in 2022 before it dropped 16.23% in 2025.
- Over 5 years, Operating Expenses stood at $3.8 million in 2022, then surged by 41.67% to $5.4 million in 2023, then fell by 7.23% to $5.0 million in 2024, then skyrocketed by 118.43% to $10.9 million in 2025, then decreased by 0.82% to $10.8 million in 2026.
- Business Quant data shows Operating Expenses for IMMX at $10.8 million in Q1 2026, $10.9 million in Q4 2025, and $7.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 2.97 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 4.33 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -138.30 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 15.76 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.85 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.96 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.82 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 898.54 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | 10.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.80 Mn |
| Dec 31, 2025 | 10.89 Mn |
| Sep 30, 2025 | 7.66 Mn |
| Jun 30, 2025 | 6.72 Mn |
| Mar 31, 2025 | 4.68 Mn |
| Dec 31, 2024 | 4.99 Mn |
| Sep 30, 2024 | 7.39 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Mar 31, 2024 | 5.59 Mn |
| Dec 31, 2023 | 5.38 Mn |
| Sep 30, 2023 | 4.52 Mn |
| Jun 30, 2023 | 3.72 Mn |
| Mar 31, 2023 | 2.52 Mn |
| Dec 31, 2022 | 3.79 Mn |
| Sep 30, 2022 | 1.53 Mn |
| Jun 30, 2022 | 1.56 Mn |
| Mar 31, 2022 | 1.33 Mn |
| Dec 31, 2021 | 598,338.00 |
| Sep 30, 2021 | 347,991.00 |
| Jun 30, 2021 | 243,165.00 |
| Mar 31, 2021 | 162,520.00 |